Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seitz, U.
Right arrow Articles by Reske, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seitz, U.
Right arrow Articles by Reske, S. N.
[Cancer Research 61, 3853-3857, May 15, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

In Vivo Evaluation of 5-[18F]Fluoro-2'-deoxyuridine as Tracer for Positron Emission Tomography in a Murine Pancreatic Cancer Model

Ulrike Seitz1,, 2, Martin Wagner1, Andreas T. Vogg, Gerhard Glatting, Bernd Neumaier, Florian R. Greten, Roland M. Schmid and Sven N. Reske

Departments of Nuclear Medicine [U. S., A. T. V., G. G., B. N., S. N. R.] and Internal Medicine I [M. W., F. R. G., R. M. S.], University of Ulm, 89081 Ulm, Germany

We used a murine tumor progression model for the evaluation of potential proliferation markers using positron emission tomography (PET). 5-[18F]-2'-deoxyuridine ([18F]FdUrd) was synthesized with >98% radiochemical purity and investigated in a pancreatic cancer model, transforming growth factor {alpha} transgenic mice crossbred to p53 deficient mice. Thymidylate synthase was increased already in premalignant lesions, whereas thymidine kinase 1 mRNA levels were up-regulated 4-fold in the pancreatic cancer specimen of these mice. PET imaging was performed after injection of 1 MBq of [18F]FdUrd and 1 MBq of [18F]fluoro-deoxyglucose. Animals with pancreatic cancer displayed focal uptake of both tracers. The [18F]FdUrd uptake ratio closely correlated with the proliferation index as evaluated in morphometric and fluorescence-activated cell sorter analysis. These results indicate the potential of our tumor model for the evaluation of PET tracers and suggest [18F]FdUrd as a tracer for the assessment of proliferation in vivo.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Wagner, U. Seitz, A. Buck, B. Neumaier, S. Schultheiss, M. Bangerter, M. Bommer, F. Leithauser, E. Wawra, G. Munzert, et al.
3'-[18F]Fluoro-3'-Deoxythymidine ([18F]-FLT) as Positron Emission Tomography Tracer for Imaging Proliferation in a Murine B-Cell Lymphoma Model and in the Human Disease
Cancer Res., May 15, 2003; 63(10): 2681 - 2687.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.